AIM VACCINE CO LTD
(HKEX: 6660)
AIM Vaccine Co., Ltd. engages in biological vaccine technology development, technology transfer, and technical services. Its products include Recombinant hepatitis B vaccine, Freeze-dried Human Rabies vaccine, Inactivated Hepatitis A vaccine, Live Attenuated Parotitis vaccine, Inactivated HFRS vaccine, and ACYW135 Meningococcus Polysaccharide vaccine. The company was founded on November 9, 2011 and is headquartered in Beijing, China.
2.700 -
-0.070
(-2.53%)
Range
2.680 - 2.800
(4.48%)
Open
2.800
Previous Close
2.770
Bid Price
2.700
Bid Volume
('000)
68
Ask Price
2.710
Ask Volume
('000)
25.6
Volume
('000)
521.6
Value
1,431,638
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
